An interesting bioethics debate

Does early detection work? __The New York Times__ today posts a linkurl:story about Claudia Henschke,;http://www.nytimes.com/2006/10/31/health/31prof.html a radiology professor at Weill Cornell Medical College who?s pushing for routine CT scans to detect lung cancer earlier. The phrases are so well trodden, they?re often taken at face value: ?We?re lucky we caught it in time,? or ?If only we?d found it sooner.? The problem with simply accepting that earlier detection means better survival i

Written byBrendan Maher
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Does early detection work? __The New York Times__ today posts a linkurl:story about Claudia Henschke,;http://www.nytimes.com/2006/10/31/health/31prof.html a radiology professor at Weill Cornell Medical College who?s pushing for routine CT scans to detect lung cancer earlier. The phrases are so well trodden, they?re often taken at face value: ?We?re lucky we caught it in time,? or ?If only we?d found it sooner.? The problem with simply accepting that earlier detection means better survival is that it?s largely just an assumption. Yes, evidence strongly suggests that colonoscopy prevents death from colon cancer. But colon cancer and lung cancer are different. All cancers are different. To make a recommendation of routine screening, surely there should be some data showing that it doesn?t 1) raise false alarms over small but benign tumors or 2) miss fast growing, aggressive tumors that may be responsible for most cancer deaths. We?ll have more on this in November as Emanuel Petricoin and Lance Liotta square off against Barnett Kramer on using proteomics as a method for early detection. The Times? wrote a linkurl:front page story;http://www.nytimes.com/2006/10/26/health/26lung.html on Henschke?s recent uncontrolled study in __New England Journal of Medicine__ just last week. Today?s story paints Henschke as a bit of a maverick and details her frustration with what the writer calls a wet blanket statement from the ACS and the NCI: ?needs more research.? Would a controlled study limit access to a lifesaving technique? Would the technique even be cutting edge at the end of the study? Would it merely result in more dangerous surgeries and biopsies for harmless tumors. It?s an interesting debate on the nature of scientific research, and its gold standard to test every hypothesis, meeting head on with medicines? do-no-harm tenet.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform